PK/PD Study of Gan & Lee's Insulin Glargine Injection in Comparison to Lantus in Type 1 Diabetes

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
This is a Phase 1, exploratory, single dose, randomized, double-blind, two-way cross over, pilot, glucose clamp study to assess pharmacokinetic and pharmacodynamic effects of Gan \& Lee\'s insulin glargine injection in comparison to the marketed Lantus (US) in subjects with type 1 diabetes mellitus (T1DM).
Epistemonikos ID: cbe5ba2d5e7d75a5960ab8fed862ee4740511858
First added on: May 12, 2024